A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

Clinical trial NCT04064060 · RECRUITING

Trial details

NCT number: NCT04064060
Sponsor: Celgene
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Myelodysplastic Syndromes (MDS)Beta-thalassemia Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis

Start date: 2019-08-12
Primary completion: 2028-05-12
Enrollment: 665

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.